Evolve Biologics
Derek Butler's work experience begins in 2008 as a Production Operator at CSL Behring, where they worked until 2010. Derek then became a Production Supervisor at CSL Behring from 2010 to 2011. In 2011, Derek joined Fresenius Kabi USA as a Production Supervisor, where they worked until 2013. Derek then returned to CSL Behring as a Production Supervisor from 2013 to 2018, before transitioning to the role of Operational Readiness Lead until 2021. Currently, Derek is employed at Evolve Biologics as a Commercial Facility Operations Lead, starting in 2021.
Derek Butler completed their Bachelors degree in Insurance at Illinois State University. Derek attended the university from 2004 to 2008.
This person is not in any offices
Evolve Biologics
Evolve Biologics Inc. offers the development and commercialization of plasma-derived therapeutics, using its proprietary PlasmaCap EBA purification technology to more efficiently and effectively meet growing global patient demand for these life-saving products. The Company is currently in the process of commercializing an exciting and innovativeportfolio of product candidates, including IVIG (intravenous immunoglobulin) and Albumin (human serum albumin), both of which are in advanced stages of regulatory approval in the US (FDA) and Canada (Health Canada).